MDinteractive is an approved CMS Qualified Registry for 2021.

Miss our APM Performance Pathway Webinar? Watch it now!

MDinteractive accepting customers for Primary Care First program.

Join us for our 2021 MIPS Overview Webinar on Wednesday, June 16 at 1 p.m. EST. Register here.

2020 MIPS IA_PSPA_26: Communication of Unscheduled Visit for Adverse Drug Event and Nature of Event

Activity ID

IA_PSPA_26

Activity Weighting

Medium

Subcategory Name

Patient Safety and Practice Assessment

Activity Description

A MIPS eligible clinician providing unscheduled care (such as an emergency room, urgent care, or other unplanned encounter) attests that, for greater than 75 percent of case visits that result from a clinically significant adverse drug event, the MIPS eligible clinician provides information, including through the use of health IT to the patient's primary care clinician regarding both the unscheduled visit and the nature of the adverse drug event within 48 hours. A clinically significant adverse event is defined as a medication-related harm or injury such as side-effects, supratherapeutic effects, allergic reactions, laboratory abnormalities, or medication errors requiring urgent/emergent evaluation, treatment, or hospitalization.

Validation

Demonstration of communication from the eligible clinician/group providing unscheduled care for a clinically significant adverse drug event to the patient's primary care provider

Suggested Documentation

1) Documentation of an unscheduled clinically significant adverse event, defined as a medication-related harm or injury such as side-effects, supratherapeutic effects, allergic reactions, laboratory abnormalities, or medication errors requiring urgent/emergent evaluation, treatment, or hospitalization.
2) Documentation of communication of the event to the patient's primary care clinician within 48 hours of the unscheduled event.

Register with MDinteractive